15177-67-0 Usage
Description
TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID MONOMETHYL ESTER, also known as a carboxylic acid ester derivative, is an organic compound with the molecular formula C9H14O4. It is characterized by its unique cyclic structure and ester functional group, which contributes to its chemical properties and potential applications.
Uses
Used in Chemical Synthesis:
TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID MONOMETHYL ESTER is used as an organic reagent for the synthesis of various chemical compounds. Its ester functional group allows for further reactions and modifications, making it a versatile building block in organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID MONOMETHYL ESTER is used as a key intermediate in the production of certain drugs. Its unique structure and reactivity enable the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Material Science:
TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID MONOMETHYL ESTER is also utilized in the field of material science, where it can be employed in the development of novel polymers and other advanced materials. Its cyclic structure and ester group provide opportunities for creating materials with specific properties, such as enhanced strength, flexibility, or chemical resistance.
Used in Research and Development:
In research and development, TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID MONOMETHYL ESTER serves as a valuable compound for studying the properties and behavior of carboxylic acid esters. It can be used to explore new reaction pathways, investigate the effects of structural modifications, and develop a deeper understanding of the underlying chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 15177-67-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,1,7 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15177-67:
(7*1)+(6*5)+(5*1)+(4*7)+(3*7)+(2*6)+(1*7)=110
110 % 10 = 0
So 15177-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H14O4/c1-13-9(12)7-4-2-6(3-5-7)8(10)11/h6-7H,2-5H2,1H3,(H,10,11)/t6-,7+
15177-67-0Relevant articles and documents
Magnetic Field Dependent Reaction Yields from Radical Ion Pairs Linked by a Partially Rigid Aliphatic Chain
Werner, Udo,Kuehnle, Wolfgang,Staerk, Hubert
, p. 9280 - 9287 (1993)
The electron donor-acceptor compound pyrene-(CH2)3-cyclohexane-(CH2)3-dimethylaniline, abbreviated as Py3(C6)3DMA, has been investigated.Photoinduced electron transfer leads to the singlet radical ion pair Py-3(C6)3DMA+.An extraordinary large and distinct magnetic field effect is observed in the yield of the locally excited triplet state of the pyrene moiety, the recombination product of the triplet radical ion pair.The half-width of the "J-resonance" maximum in the magnetic field dependent triplet yield curve is just 66 G, corresponding to 7.7*10-7 eV or 6.2*10-3 cm-1.This is due to the influence of the rigid trans-cyclohexane part in the aliphatic chain, which leads to a reduced intramolecular mobility and to a narrow probability distribution of the radical ion pair distance, as predicted by Monte-Carlo computer simulations.The magnetic field dependence of the triplet generation is further transmitted to secondary reactions like triplet-triplet annihilation, thus leading to a magnetic field dependent delayed fluorescence and to a delayed excimer fluorescence.
BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00752-00754, (2019/06/05)
Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1 ), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.
Polymerizable compound, composition, polymer, an optically anisotropic material, an organic EL element and a liquid crystal display element
-
Paragraph 0133; 0134, (2016/10/10)
An object of the invention is to provide polymerizable compounds having excellent optical characteristics and suited as materials for optically anisotropic articles, compositions containing the polymerizable compounds, polymers obtained by polymerizing th